Successful treatment with ponatinib for central nervous system relapse of Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia
- 10 October 2019
- journal article
- letter
- Published by Wiley in Internal Medicine Journal
- Vol. 49 (10), 1332-1334
- https://doi.org/10.1111/imj.14451
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: the possible role of ponatinibExpert Opinion on Drug Safety, 2018
- Does ponatinib cross the blood–brain barrier?British Journal of Haematology, 2016
- The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemiaExpert Review of Anticancer Therapy, 2015
- Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemiaBlood, 2008